Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis

Ndjeka, Norbert; Conradie, Francesca; Schnippel, Kathryn; Hughes, Jennifer; Bantubani, Nonkqubela; Batista Ferreira, Héverson; Maartens, Gary; Mametja, David; Meintjes, Graeme; Padanilam, Xavier; Variava, Ebrahim; S. Pym, Alexander; Pillay, Yogan

doi:10.5588/ijtld.14.0944

Public

Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis

Published in The International Journal of Tuberculosis and Lung Disease • Jul 10, 2015

Authors:

Norbert Ndjeka

Francesca Conradie

Kathryn Schnippel

Abstract

BACKGROUND: South Africa has a large burden of extensively drug-resistant tuberculosis (XDR-TB); only 15% of XDR-TB patients have successful outcomes. OBJECTIVE: To describe the safety and effectiveness of bedaquiline (BDQ) in the South African BDQ Clinical Access Programme. DESIGN: An interim cohor...

Subject

Bedaquiline

Medicine

Tuberculosis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!